It is important to add, the fact that only 25 out of the 40 collected samples could be used was due to the patient population recruited initially ("Participants may have Grades C and D aGVHD involving the skin, liver and/or gastrointestinal (GI) tract or Grade B aGVHD involving the liver and/or GI tract, with or without concomitant skin disease." - https://clinicaltrials.gov/study/NCT02336230) vs. the high risk sub-group (based on MAGIC serum biomarkers, high risk, reflecting active gastrointestinal inflammation and high risk for 6-month NRM) of the sub-group that was filtered out as a result of prior Osiris/MSB trials - could be called a hindsight 20/20 insight.
This is where the FF delay may have not been entirely bad and may have saved us a some money running a trial that may have targeted too broad of a patient population, also potentially requiring a further sub-sub-subgroup post hoc analysis. Instead, the P2 trial is aiming to recruit:
"HR-aGvHD must meet one of the following clinical features within 72 hours prior to randomization: (a) high-risk as per Refined Minnesota Criteria; OR (b) One of the following: (i) isolated stage 2 involvement of the lower GI tract; (ii) Stage 1 lower GI tract disease with skin involvement."
https://clinicaltrials.gov/study/NCT05643638?term=cynata&city=&checkSpell=false&rank=1
Some may consider that "$50 million in near-term cash and stock and up to $50 million more in milestones" saved - if KK is correct.
- Forums
- ASX - By Stock
- Ann: Investor Presentation
It is important to add, the fact that only 25 out of the 40...
-
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYP (ASX) to my watchlist
|
|||||
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $52.99M |
Open | High | Low | Value | Volume |
28.0¢ | 29.5¢ | 27.5¢ | $29.94K | 106.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 27.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.5¢ | 10159 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 0.275 |
1 | 1492 | 0.270 |
1 | 77000 | 0.260 |
2 | 9125 | 0.245 |
3 | 125942 | 0.240 |
Price($) | Vol. | No. |
---|---|---|
0.295 | 10159 | 1 |
0.310 | 16591 | 3 |
0.325 | 15000 | 1 |
0.340 | 100000 | 1 |
0.345 | 6124 | 1 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online